Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 19, 2021

Associations of Disease-Modifying Therapies With COVID-19 Severity in MS



Additional Info

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Neurology 2021 Nov 09;97(19)e1870-e1885, S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, G Edan, Y Moreau, T Spelman, L Geys, T Parciak, C Gautrais, N Lazovski, A Pirmani, A Ardeshirdavanai, L Forsberg, A Glaser, R McBurney, H Schmidt, AB Bergmann, S Braune, A Stahmann, R Middleton, A Salter, RJ Fox, A van der Walt, H Butzkueven, R Alroughani, S Ozakbas, JI Rojas, I van der Mei, N Nag, R Ivanov, G Sciascia do Olival, AE Dias, M Magyari, D Brum, MF Mendes, RN Alonso, RS Nicholas, J Bauer, AS Chertcoff, A Zabalza, G Arrambide, A Fidao, G Comi, L Peeters

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading